SCHEMBL5011876

SCHEMBL5011876

Ic1cs[c]n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL533958 0.65 — —
SCHEMBL3125602 0.65 — —
SCHEMBL7458711 0.65 — —
SCHEMBL533260 0.65 — —
SCHEMBL972112 0.62 — —
SCHEMBL1339121 0.60 — —
SCHEMBL313140 0.60 — —
SCHEMBL314388 0.60 — —
SCHEMBL4723588 0.60 — —
SCHEMBL313087 0.60 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109842-A1 ACRYLAMIDE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2024-04-04 — — US disclosed
CN-114667280-A Acrylamide compound 大塚制药株式会社 2022-06-24 — — CN disclosed
WO-2021117733-A1 ACRYLAMIDE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2021-06-17 — — WO disclosed
CN-101163699-A Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof MEDPOINTE HEALTHCARE INC (US) 2008-04-16 — — CN disclosed
EP-1888570-A2 METHODS FOR SYNTHESIS OF DICARBAMATE COMPOUNDS AND INTERMEDIATES IN THE FORMATION THEREOF MedPointe Healthcare Inc. (US) 2008-02-20 — — EP disclosed
WO-2006116007-A2 METHODS FOR SYNTHESIS OF DICARBAMATE COMPOUNDS AND INTERMEDIATES IN THE FORMATION THEREOF MEDPOINTE HEALTHCARE INC. (US) 2006-11-02 — — WO disclosed
US-20060241298-A1 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof MEDPOINTE HEALTHCARE INC. 2006-10-26 — — US disclosed
Send feedback